ŚCO Kielce
Published on ŚCO Kielce (https://onkol.kielce.pl)

Strona główna > Cereblon (CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

Cereblon (CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium [1]

Title: Cereblon (CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium
Author(s): Iskierka-Jazdzewska, Elzbieta; Stepien, Anna; Canzian, Federico; et al.
Source: Blood Volume: 124 Issue: 21 Published: 2014
Times Cited: 0

Nauka [2]

Source URL:https://onkol.kielce.pl/pl/nauka/cereblon-crbn-gene-polymorphisms-predict-clinical-response-and-progression-free-survival

Links
[1] https://onkol.kielce.pl/pl/nauka/cereblon-crbn-gene-polymorphisms-predict-clinical-response-and-progression-free-survival [2] https://onkol.kielce.pl/pl/sekcja/nauka